← All stories
Definium Therapeutics
American clinical-stage biopharmaceutical company developing psychedelic-based treatments
- HQ
- NEW YORK, NY
- Industry
- Medicinal Chemicals & Botanical Products
- Country
- US
In the news · 2
Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Announced positive topline results from Phase 3 Emerge study of DT120 ODT in major depressive disorder (MDD), demonstrating rapid, robust, and durable efficacy Topline results from Phase 3 GAD studies of DT120 ODT in generalized anxiety disorder (GAD) on track: Voyage results ant…
1 source
·1d ago
More in Healthcare